Dengue: a minireview
Dengue, caused by infection of any of four dengue virus serotypes (DENV-1 to DENV-4), is a
mosquito-borne disease of major public health concern associated with significant morbidity …
mosquito-borne disease of major public health concern associated with significant morbidity …
[HTML][HTML] Dengue: a growing problem with new interventions
Dengue is the disease caused by 1 of 4 distinct, but closely related dengue viruses (DENV-1–
4) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral …
4) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral …
Guidelines for the use of platelet transfusions
L Estcourt, J Birchall, S Allard, S Bassey… - British journal of …, 2016 - ora.ox.ac.uk
The demand for platelets in England was stable at around 220,000 adult therapeutic doses
(ATD) per year until 2007/8 at which point demand has increased year on year to 275,000 …
(ATD) per year until 2007/8 at which point demand has increased year on year to 275,000 …
Dengue: update on clinically relevant therapeutic strategies and vaccines
M Palanichamy Kala, AL St. John… - Current Treatment Options …, 2023 - Springer
Opinion statement Dengue viruses (DENV) continue to circulate worldwide, resulting in a
significant burden on human health. There are four antigenically distinct serotypes of DENV …
significant burden on human health. There are four antigenically distinct serotypes of DENV …
Management of dengue: an updated review
A Tayal, SK Kabra, R Lodha - Indian Journal of Pediatrics, 2023 - Springer
Dengue is an important public health problem with a wide clinical spectrum. The World
Health Organization classifies dengue into probable dengue, dengue with warning signs …
Health Organization classifies dengue into probable dengue, dengue with warning signs …
Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label …
Background Dengue is the commonest vector-borne infection worldwide. It is often
associated with thrombocytopenia, and prophylactic platelet transfusion is widely used …
associated with thrombocytopenia, and prophylactic platelet transfusion is widely used …
[HTML][HTML] Recent advances in dengue pathogenesis and clinical management
CP Simmons, K McPherson, NVV Chau, DTH Tam… - Vaccine, 2015 - Elsevier
This review describes and commentates on recent advances in the understanding of
dengue pathogenesis and immunity, plus clinical research on vaccines and therapeutics …
dengue pathogenesis and immunity, plus clinical research on vaccines and therapeutics …
[HTML][HTML] Immuno-Haematologic aspects of dengue infection: biologic insights and clinical implications
TJJ Cherie, CSH Choong, MB Abid, MW Weber… - Viruses, 2024 - mdpi.com
Dengue infection is caused by the dengue virus (DENV) and is transmitted to humans by
infected female Aedes aegypti and Aedes albopictus mosquitoes. There are nearly 100 …
infected female Aedes aegypti and Aedes albopictus mosquitoes. There are nearly 100 …
Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions
Dengue is the most common arboviral disease of humans. There is an unmet need for a
therapeutic intervention that reduces the duration and severity of dengue symptoms and …
therapeutic intervention that reduces the duration and severity of dengue symptoms and …
Dengue: an update on treatment options
CYY Chan, EE Ooi - Future microbiology, 2015 - Taylor & Francis
Dengue is the most important mosquito-borne viral pathogen globally, with approximately
100 million cases of acute dengue annually. Infection can result in severe, life-threatening …
100 million cases of acute dengue annually. Infection can result in severe, life-threatening …